⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RPTX News
Repare Therapeutics Inc. Common Shares
Global Gene Therapy Market Size, Share, Growth, and Forecast 2026-2035 | USD 74.78 Billion Opportunity Driven by Rare Disease R&D, Viral Vectors, and Regulatory Approvals
globenewswire.com
AMGN
BIIB
GILD
SANG
NTLA
RPTX
EDIT
CRSP
GNPX
ASTL
Recurrent Head And Neck Squamous Cell Carcinoma Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 65+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
GSK
JNJ
MRK
REGN
BIIB
EXEL
IOBT
INO
GMAB
IMUX
NVCR
PDSB
BNTX
CRSP
MRNA
RPTX
PRE
TRNS
INVZ
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
CUE
GMAB
IMPP
INO
AZN
GSK
MRK
BMY
EXEL
REGN
PDSB
IOVA
RPTX
Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management
globenewswire.com
RPTX
AMRX
TREOS Bio Appoints Sunjeet Sawhney as Chief Executive Officer
globenewswire.com
RPTX
NVS
Catalyst Monitor: Q2 2026 Outlook Report - Trial Initiations, Completions, Top-line Results, Regulatory Filings, PDUFA Dates, and Expected Approvals
globenewswire.com
RPTX
ARVN
RGNX
Reveal Expands Private Deployment Investment by 50% as Enterprise Demand Surges
businesswire.com
RPTX
CSL
Repare Announces Completion of Acquisition by XenoTherapeutics, Inc.
businesswire.com
RPTX
Grocery TV Adds to Leadership Team as In-Store Retail Media Accelerates
prnewswire.com
WMT
CRTO
VOLT
RPTX
Clinical Data Management System Market Report 2026: Trends, Strategies and Investments | Astute Analytica
globenewswire.com
PFE
IQV
ORCL
MED
RPTX
ICLR
AZN
JNJ